Evaxion Biotech ( ($EVAX) ) has shared an update. On November 3, 2025, Evaxion A/S announced the expansion of its R&D pipeline with the ...

The biotechnology industry has long been characterized by astronomical development costs and lengthy timelines that can stretch into decades. Traditional ...

A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes ...

CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Flare Therapeutics Inc. (FlareTx), a clinical-stage biotechnology company targeting transcription factors to discover precision medicines for ...

Evaxion introduces EVX-04, a novel vaccine candidate targeting multiple non-conventional ERV tumor antigens, developed withour AI-Immunology™ ...

Nanobiotix is continuing to find fresh ways to eke money out of its Johnson & Johnson-partnered, phase 3-stage cancer drug. | ...

Lumen Biosciences Brian Finrow breaks down Chinas biotech playbook and explores ways the U.S. can adapt it for its own continued success.

The Council for Scientific and Industrial Research (CSIR) has assured Ghanaians that Genetically Modified (GM) foods, particularly the Pod Borer Resistant (PBR) cowpea, were safe, nutritious, and ...

Australian startup Uluu has secured over €7 million in Series A funding to build a demonstration plant for the industrial ...

Transferring one species to another is how to create genetically modified organisms, or GMOs. This creates something not ...

AIMPLAS, the Technology Centre, hosted the second edition of the International Seminar on Plastic Characterization, CHARPLAST ...

A start-up should always have a “plan B” to provide a critical safety net. A considerable and expensive amount of redundant lab equipment can sit idle if that pivot arises and prompts a significant ...